EFM
TNGX icon

E Fund Management’s Tango Therapeutics TNGX Stock Holding History

E Fund Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$353K Sell
11,301
-1,893
-14% -$46.8K 0.01% 356
2026
Q1 		$276K Buy
+13,194
New +$184K 0.01% 407
2024
Q2 		– Sell
-10,398
Closed -$82.6K – 374
2024
Q1 		$82.6K Buy
+10,398
New +$111K 0.01% 365

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

E Fund Management's TNGX Position: Q2 2026 in Review

E Fund Management reduced its Tango Therapeutics (TNGX) stake by 14% in Q2 2026, selling an estimated $46.8K and leaving 11,301 shares worth $353K. The position accounts for 0.01% of the portfolio, ranked #356.

E Fund Management first reported a position in TNGX in Q1 2024 and has held it in 3 quarters since. 247 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • E Fund Management held 11,301 shares of Tango Therapeutics worth $353K as of Q2 2026.
  • E Fund Management sold 1,893 Tango Therapeutics shares in Q2 2026, an estimated $46.8K.
  • Tango Therapeutics made up 0.01% of E Fund Management's portfolio in Q2 2026, its #356 holding.
  • E Fund Management first reported a position in Tango Therapeutics in Q1 2024 and has held it in 3 quarters since.
  • 247 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.